GHO Capital

GHO Capital Partners LLP is a private equity firm established in 2014, specializing in investments within the healthcare sector. Based in London, with an additional office in Durham, North Carolina, the firm focuses on buyouts and mid-market companies, targeting enterprises with values between €100 million and €400 million. GHO Capital primarily invests in areas such as outsourced services, pharmaceuticals, medical technology, diagnostics, and patient services. The firm aims to leverage its expertise to capitalize on the attractive and underpenetrated opportunities within the European healthcare market.

Chris Benson

Vice President

Brad Cain

Director

Alex Cox

Vice President

Holly Cromar

Senior Associate

Cédric Degryse

Vice President

Ken Eichmann

Partner

Gareth Fitzgerald

Director

David Hall

Director

Youssef Hegazi

Senior Associate

Matthew Holdom

Senior Associate

Nico Iacuzzi

Principal

Katri Inki

Associate

Claire Jaouen

Senior Associate

Charles Leong

Vice President

Alan Browning MacKay

Managing Partner and Founder

Alessandra Macmillan

Senior Associate

Hendrik Michaelis

Associate

Edward de Nor

Partner

Sabina Ouimet-Storrs

Principal

Andrea Ponti

Managing Partner and Founder

Manuela Rankine

Director of Sustainable Investing

Charles Ruprecht

Director

Robert Saltrick

Director

Leo Shui

Principal

Turner, Michael Paul Charles

Partner

Camilla Veroni

Associate

19 past transactions

Lykan Bioscience

Private Equity Round in 2022
Lykan Bioscience, LLC specializes in providing outsourced clinical and commercial manufacturing services tailored for pharmaceutical and biotechnology companies. Established in 2017 and headquartered in Phoenix, Arizona, the company focuses on delivering comprehensive production and logistics solutions. Its offerings include point-of-care services, tech transfer, manufacturing, quality program management, and supply chain management. Lykan's manufacturing and logistics processes are designed to enhance quality, efficiency, and throughput, particularly in the realm of autologous and allogeneic cell and gene therapies. By streamlining operations, Lykan aims to reduce the time required to complete clinical trials, thereby supporting the development of life-saving therapies.

RoslinCT

Private Equity Round in 2022
RoslinCT is a prominent UK-based contract development and manufacturing organization specializing in cell therapy. The company offers a range of services tailored for organizations developing cell-based therapeutic products, including cell and gene therapy development, tissue procurement, and cryopreservation studies. Additionally, RoslinCT conducts pre-clinical studies and analytical development, ensuring that clients can deliver compliant, sustainable, and affordable therapies. Through its expertise, RoslinCT supports the advancement of innovative treatments in the field of regenerative medicine.

Biocare Medical

Private Equity Round in 2021
Biocare Medical, LLC is a developer and supplier of automated immunohistochemistry (IHC) instrumentation and a comprehensive range of reagents for IHC lab testing. The company offers integrated tissue diagnostic products aimed at cancer and infectious diseases, including primary antibodies and detection kits for use in clinical histology laboratories, pharmaceutical companies, contract research organizations, and academic institutions. Biocare Medical specializes in multiplex IHC tests, enhancing diagnostic confidence and accelerating turnaround times. Its product portfolio includes advanced micro-polymer detection systems, chromogens, fluorescence detection products, and various laboratory supplies such as decalcification agents and antibody diluents. Additionally, the company provides technical support and training services. Founded in 1997 and based in Pacheco, California, Biocare Medical has established a global distribution network and maintains a strategic partnership with Applied Spectral Imaging Inc.

Sanner Group

Private Equity Round in 2021
Manufacturer of plastic packaging components intended to reduce energy consumption and co2 emissions while using materials more efficiently. The company produces effervescent tablets and test strips, desiccant sachets, capsules, caps, plastic tubes, closures, glass bottles and aluminum tubes, enabling customer-specific solutions in the fields of medical technology and diagnostics, pharmaceuticals and consumer healthcare.

ClearView Healthcare Partners

Acquisition in 2021
ClearView Healthcare Partners LLC is a global strategy consulting firm based in Newton, Massachusetts, specializing in the life sciences sector. Founded in 2007, the firm offers strategic consulting services to a diverse clientele that includes emerging biotechnology companies, medical device firms, and large pharmaceutical corporations. ClearView focuses on a variety of areas, including pharmaceuticals, biotechnology, medical devices, and diagnostics. Its services encompass strategic engagements such as indication prioritization, long-term therapeutic area strategy, due diligence, and clinical development strategy. Additionally, the firm provides support in new product planning, strategic marketing, corporate development, and market research. By leveraging extensive industry knowledge and scientific expertise, ClearView delivers practical and actionable recommendations to address complex challenges faced by its clients in the global life sciences landscape.

Velocity Clinical Research

Acquisition in 2021
Velocity Clinical Research specializes in delivering clinical trial data and research services to biopharmaceutical and contract research organizations. The company is dedicated to facilitating the successful execution of clinical studies, focusing on maintaining high standards of care while efficiently bringing new medications to patients. Velocity provides a centralized point of contact for various aspects of clinical trials, including feasibility assessments, contracting, patient recruitment, study management, and billing. Its commitment to enhancing the clinical research process spans multiple therapeutic areas, ensuring that innovative medical treatments reach those in need as swiftly as possible.

Envision Pharma Group

Acquisition in 2020
The Envision Pharma Group, an innovative scientific communications and technology company, focused on the life science industry. We are an industry leader in medical publication planning, execution, consultancy, and technology. We work with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner. Our team members are sought-after industry leaders who are often consulted in publications policy, process, metrics, change management, and technology. To match the needs of our clients, we are flexible in our approach to business – be it in team design and make up, payment models, offering whole solutions or key components, transfer of knowledge, or project timescales.

X-Chem

Acquisition in 2020
X-Chem, Inc. is a privately held biotechnology company located in Waltham, Massachusetts, founded in 2009. The company specializes in discovering small molecule leads for high-value therapeutic targets, utilizing its innovative DNA-Encoded Library (DEL) technology. This approach allows X-Chem to provide drug discovery services through the iterative combinatorial synthesis of small molecules, which are linked to DNA tags that document their synthetic history. By focusing on the generation of novel small molecule therapeutics, X-Chem aims to advance healthcare through its cutting-edge biotechnological services.

Fairjourney Biologics

Venture Round in 2020
Fairjourney Biologics SA is a contract research organization based in Porto, Portugal, specializing in antibody discovery services. Founded in 2012, the company offers a range of outsourced services that include the development of therapeutics, pharmacokinetic tools, anti-drug tools, diagnostics, and imaging tools. Additionally, Fairjourney provides research tools featuring various types of antibodies, such as Llama VHHS, rodent, rabbit, human, and chicken antibodies. The organization also focuses on antibody engineering, offering services like affinity maturation, humanization, and sequence optimization, alongside antibody production services that involve the recombinant expression of antibodies and their fragments. Since its inception, Fairjourney Biologics has experienced rapid growth and has maintained profitability, reflecting its expertise in the field and fostering stable partnerships within the industry.

Ardena

Acquisition in 2020
Ardena Group is a pharmaceutical development company that offers a comprehensive range of services to support drug development from the initial molecule stage to clinical application. The company provides drug substance and drug product development, clinical logistics, bioanalysis, and dossier preparation services. Founded in 1994 and based in Mariakerke, Belgium, Ardena Group aims to facilitate the transition of pharmaceutical products from the laboratory to clinical settings, ensuring that clients receive tailored support throughout the development process.

Sterling Pharma Solutions

Acquisition in 2019
Sterling Pharma Solutions is a company that offers development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. It specializes in providing outsourced contract manufacturing services, including medical engineering, project management, and supply chain management. By delivering contract good manufacturing practices (GMP) services, Sterling enables its clients to concentrate on their projects throughout the entire product lifecycle, facilitating the efficient development and production of pharmaceuticals.

BioAgilytix Labs

Venture Round in 2019
BioAgilytix is a bioanalytical lab specializing in immunoassays and cell-based assays. Located in Research Triangle Park North Carolina, our growing team of highly dedicated individuals is driven by the desire to support the development of novel drugs and other scientific breakthroughs. By employing highly experienced scientists with deep, focused expertise in an engaging work environment, we are able to consistently exceed our customers’ expectations.

Validant

Acquisition in 2018
Validant is a consulting firm that specializes in compliance and regulatory affairs for the pharmaceutical, biologics, medical device, and diagnostics sectors. The company provides a range of services, including systems design, strategy development, implementation, and responses to health authority enforcement actions. Additionally, Validant offers remediation services to ensure that healthcare products are safe and reliable. Their extensive and versatile network of subject matter experts allows clients to access specialized knowledge tailored to their specific initiatives, enabling prompt and effective support in navigating regulatory challenges.

Linimed

Acquisition in 2018
Linimed GmbH, headquartered in Jena, Germany, specializes in home nursing and outpatient care services, focusing on 24/7 intensive care for patients with severe health issues, including neurological and neuromuscular diseases as well as obstructive respiratory diseases. Founded in 1994, the company operates 52 community care centers across Germany, providing care to approximately 250 intensive care patients. With around 930 employees, Linimed is recognized for delivering high-quality, efficient care while maintaining lower costs within the healthcare system. The company emphasizes comprehensive support through its services, which include out-of-hospital intensive care, home nursing, assisted living, and daycare, aimed at improving the health and well-being of its patients.

Alcaliber

Acquisition in 2018
Alcaliber is a independent supplier of Active Pharmaceuticals Ingredients to the global pharmaceutical industry. The Company is headquartered in Spain and has a 45-year track record of best-in-class industrial operations in a tightly regulated subsector niche with high barriers to entry. Alcaliber and its specialist subsidiary, Linneo Health, are sector leading businesses with state of the art production facilities and a reputation for quality of product resulting in stable, sustainable growth.

CellCarta

Acquisition in 2016
Caprion Proteomics, Inc. is a clinical research organization based in Montreal, Canada, specializing in proteomics and immune monitoring services tailored for the pharmaceutical and biotechnology sectors. The company provides two primary platforms: ImmuneCarta, which employs multiparametric flow cytometry for in-depth analysis of immune responses, and ProteoCarta, which utilizes gel-free and label-free mass spectrometry for comparative protein measurement across biological samples. Caprion's comprehensive services include biomarker discovery, cell sorting, clinical laboratory services, and various assays aimed at enhancing drug development across multiple disease areas, including autoimmune, cardiovascular, metabolic, neurology, and infectious diseases. By integrating its immune monitoring and proteomics capabilities, Caprion aims to facilitate precision medicine and streamline novel drug development processes. Founded in 2000, Caprion operates as a subsidiary of HistoGeneX NV and has established a strategic partnership with Viroclinics-DDL.

VISUfarma

Acquisition in 2016
VISUfarma B.V. is a pan-European ophthalmic specialty pharmaceutical company focused on enhancing eye health through innovative solutions. Founded in 2016 and headquartered in Amsterdam, the company has established offices across France, Germany, Italy, Spain, and the United Kingdom. VISUfarma develops, markets, and distributes a diverse range of ophthalmic products, including VisuXL Gel, Xailin HA, COQUN OS, and several other specialized formulations and devices. By providing high-quality products, VISUfarma aims to support physicians, hospitals, and medical centers in delivering effective eye care to patients throughout Europe.

DNA Diagnostics Center

Acquisition in 2015
DNA Diagnostics Center, Inc., founded in 1995 and located in Fairfield, Ohio, specializes in providing a range of DNA testing services, including paternity and family relationship tests, fertility assessments, lifestyle evaluations, veterinary testing, and forensic analysis. The company operates a genetic testing laboratory that employs advanced automated instrumentation to deliver accurate and timely results. Its services cater to consumers, government agencies, legal professionals, and healthcare practitioners, ensuring that users receive reliable information in a confidential and cost-effective manner.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.